These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 21105986)
1. Bilharzial vs non-bilharzial related bladder cancer: pathological characteristics and value of cyclooxygenase-2 expression. Youssef R; Kapur P; Kabbani W; Shariat SF; Mosbah A; Abol-Enein H; Ghoniem M; Lotan Y BJU Int; 2011 Jul; 108(1):31-7. PubMed ID: 21105986 [TBL] [Abstract][Full Text] [Related]
2. Prognostic value of apoptotic markers in squamous cell carcinoma of the urinary bladder. Youssef R; Kapur P; Shariat SF; Arendt T; Kabbani W; Mosbah A; Abol-Enein H; Ghoneim M; Lotan Y BJU Int; 2012 Oct; 110(7):961-6. PubMed ID: 22372762 [TBL] [Abstract][Full Text] [Related]
3. [Cyclooxygenase-2-expression in bladder cancer: tumor-biological and clinical implications]. Wülfing C; Eltze E; Von Struensee D; Wülfing P; Bode ME; Bettendorf O; Piechota H; Hertle L Aktuelle Urol; 2004 Aug; 35(4):331-8. PubMed ID: 15459875 [TBL] [Abstract][Full Text] [Related]
4. [Anatomopathological aspects of 25 cases of bilharzial bladder cancer]. Nouhou PH; Mossi A Bull Soc Pathol Exot; 1996; 89(3):181-4. PubMed ID: 8998411 [TBL] [Abstract][Full Text] [Related]
5. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901 [TBL] [Abstract][Full Text] [Related]
6. Bcl-XL and Bcl-2 expression in bilharzial squamous cell carcinoma of the urinary bladder: which protein is prognostic? Hameed DA; Abdel Raheem AM; Mosad E; Hammouda HM; Kamel NA; Abdel Aziz MA Urology; 2008 Aug; 72(2):374-8. PubMed ID: 18342927 [TBL] [Abstract][Full Text] [Related]
7. Prognostic value of cyclooxygenase-2 expression in squamous cell carcinoma of the bladder. Youssef RF; Shariat SF; Kapur P; Kabbani W; Mosbah A; Abol-Enein H; Ghoniem M; Lotan Y J Urol; 2011 Mar; 185(3):1112-7. PubMed ID: 21255800 [TBL] [Abstract][Full Text] [Related]
8. Aberrant methylation of RARbeta2 and APC genes in voided urine as molecular markers for early detection of bilharzial and nonbilharzial bladder cancer. Eissa S; Swellam M; El-Khouly IM; Kassim SK; Shehata H; Mansour A; Esmat M; Nossier AI; Hamdy MA; Awad NM; El-Ahmady O Cancer Epidemiol Biomarkers Prev; 2011 Aug; 20(8):1657-64. PubMed ID: 21680534 [TBL] [Abstract][Full Text] [Related]
9. Changing patterns (age, incidence, and pathologic types) of schistosoma-associated bladder cancer in Egypt in the past decade. Salem HK; Mahfouz S Urology; 2012 Feb; 79(2):379-83. PubMed ID: 22112287 [TBL] [Abstract][Full Text] [Related]
10. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder. Margulis V; Shariat SF; Ashfaq R; Thompson M; Sagalowsky AI; Hsieh JT; Lotan Y J Urol; 2007 Mar; 177(3):1163-8. PubMed ID: 17296438 [TBL] [Abstract][Full Text] [Related]
11. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer. Osman I; Scher H; Zhang ZF; Soos TJ; Hamza R; Eissa S; Khaled H; Koff A; Cordon-Cardo C Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2247-51. PubMed ID: 9815621 [TBL] [Abstract][Full Text] [Related]
12. Cyclooxygenase-2: a possible target in schistosoma-associated bladder cancer. El-Sheikh SS; Madaan S; Alhasso A; Abel P; Stamp G; Lalani EN BJU Int; 2001 Dec; 88(9):921-7. PubMed ID: 11851614 [TBL] [Abstract][Full Text] [Related]
13. Chromosomal aberrations in Cis and Ta bilharzial bladder cancer: a theory of pathogenesis. Khaled HM; Aly MS; Mokhtar N Urol Oncol; 2004; 22(6):443-7. PubMed ID: 15610858 [TBL] [Abstract][Full Text] [Related]
14. Haematobium eggs detection in human bladder cancer and sporocysts in snail vectors: Seven cases report and a review of the Burkina Faso literature. Benerini Gatta L; Balzarini P; Cadei M; Castelli F; Grigolato P Pathol Biol (Paris); 2012 Oct; 60(5):287-90. PubMed ID: 22867954 [TBL] [Abstract][Full Text] [Related]
15. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis]. Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066 [TBL] [Abstract][Full Text] [Related]
16. Role of a schistosoma haematobium specific microRNA as a predictive and prognostic tool for bilharzial bladder cancer in Egypt. Gaber DA; Wassef RM; El-Ayat WM; El-Moazen MI; Montasser KA; Swar SA; Amin HAA Sci Rep; 2020 Nov; 10(1):18844. PubMed ID: 33139749 [TBL] [Abstract][Full Text] [Related]
17. A classification after radical cystectomy of patients with bladder cancer associated with schistosomiasis. Rafla M; Ibrahim AS; Valleron AJ; Mary JY Eur J Cancer; 1994; 30A(12):1751-6. PubMed ID: 7880599 [TBL] [Abstract][Full Text] [Related]
18. Squamous cell carcinoma of the urinary bladder. Sharfi AR; el Sir S; Beleil O Br J Urol; 1992 Apr; 69(4):369-71. PubMed ID: 1581807 [TBL] [Abstract][Full Text] [Related]
19. Genomic imbalances in Schistosoma-associated and non-Schistosoma-associated bladder carcinoma. An array comparative genomic hybridization analysis. Armengol G; Eissa S; Lozano JJ; Shoman S; Sumoy L; Caballín MR; Knuutila S Cancer Genet Cytogenet; 2007 Aug; 177(1):16-9. PubMed ID: 17693186 [TBL] [Abstract][Full Text] [Related]
20. High-throughput tissue microarray analysis of COX2 expression in urinary bladder cancer. Wild PJ; Kunz-Schughart LA; Stoehr R; Burger M; Blaszyk H; Simon R; Gasser T; Mihatsch M; Sauter G; Hartmann A Int J Oncol; 2005 Aug; 27(2):385-91. PubMed ID: 16010419 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]